Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism
Open accessThe DOI matches its Crossref record; 71 of the 73 references it cites were found in a registry or an index; 11 of the 47 sources its claims cite were checked for support.
Abstract
Despite the crucial role of the liver in glucose homeostasis, a detailed mathematical model of human hepatic glucose metabolism is lacking so far. Here we present a detailed kinetic model of glycolysis, gluconeogenesis and glycogen metabolism in human hepatocytes integrated with the hormonal control of these pathways by insulin, glucagon and epinephrine. Model simulations are in good agreement with experimental data on (i) the quantitative contributions of glycolysis, gluconeogenesis, and glycogen metabolism to hepatic glucose production and hepatic glucose utilization under varying physiological states. (ii) the time courses of postprandial glycogen storage as well as glycogen depletion in overnight fasting and short term fasting (iii) the switch from net hepatic glucose production under hypoglycemia to net hepatic glucose utilization under hyperglycemia essential for glucose homeostasis (iv) hormone perturbations of hepatic glucose metabolism. Response analysis reveals an extra high capacity of the liver to counteract changes of plasma glucose level below 5 mM (hypoglycemia) and above 7.5 mM (hyperglycemia). Our model may serve as an important module of a whole-body model of human glucose metabolism and as a valuable tool for understanding the role of the liver in glucose homeostasis under normal conditions and in diseases like diabetes or glycogen storage diseases.
Overview
CoChat Summary
TL;DR
The paper presents a detailed kinetic model of human hepatic glucose metabolism integrating insulin, glucagon, and epinephrine control via enzyme phosphorylation state. Model simulations reproduce experimental data on hepatic glucose production/utilization, glycogen storage and depletion, fasting, and hormone perturbations, and reveal high hepatic counter-regulatory capacity below 5 mM and above 7.5 mM glucose.
Key findings
- The liver switches between net hepatic glucose production (HGP) and net hepatic glucose utilization (HGU) at a set point of 6.6 mM glucose for half-filled glycogen stores, varying from 5.4 mM for empty to 7.5 mM for filled stores; the gluconeogenesis/glycolysis set point is 8.5 mM for half-filled glycogen, and the glycogenesis/glycogenolysis set point is 5.1 mM.
- In short-term fasting, HGP decreases to a constant basal rate of 7–8 µmol/kg(bw)/min around 40 h; after an overnight fast about half of HGP comes from glycogenolysis, whereas after 40 h fasting only 10% comes from glycogen and 90% from gluconeogenesis. The model predicts ∼8.5 µmol/kg(bw)/min HGP for 20 h at 3 mM glucose with 95% from gluconeogenesis, compared with experimental values of 7.56–9.8 µmol/kg(bw)/min HGP and 92–97% gluconeogenesis.
- Hormone perturbation simulations show that insulin and glucagon depletion or glucagon depletion alone reduce HGP to around 70% of basal values, while insulin depletion increases HGP to around 130%; basal glucagon is responsible for about 30% of HGP.
- The hepatic glucose response coefficient indicates an extra high capacity to counteract plasma glucose changes below 5 mM (hypoglycemia) and above 7.5 mM (hyperglycemia), with high-response regions below 4 mM and above 8 mM glucose.
Methods
- The model consists of 49 localized metabolites and 36 reactions compartmentalized into cytosol, mitochondrion, and blood, with individual kinetics for reactions and transporters; it includes allosteric regulation and hormonal regulation via phosphorylation/dephosphorylation of interconvertible enzymes (GS, GP, PFK2, FBP2, PK, and PDH).
- Experimental flux data were human-specific, metabolite concentrations were taken from human and rat liver, HGP/gluconeogenesis/glycogenolysis data came from 25 independent studies, and hormone glucose-response curves were fitted to oral glucose tolerance tests and hypoglycemic, hyperinsulinemic clamp studies.
- The differential equation system was integrated with MATLAB ode15s; steady-state and quasi-steady-state simulations varied blood glucose from 2 to 14 mM and glycogen from 0 to 500 mM, with metabolic control analysis and hepatic glucose response coefficient calculations.
Limitations
- The paper states that hormone signal transduction is phenomenological due to lack of quantitative signaling data; cellular redox and energy states are held constant; the model represents an “average” hepatocyte and neglects metabolic zonation; gene expression changes are not included; and the phosphorylation state of all regulatory enzymes is assumed equal and instantaneous.
- The paper also notes that the model comprises fairly active futile cycles in glycogen metabolism, the PFK1/FBPase1 system, and between PEPCK and PK, and that it is not able to simulate conditions where energy decoupling is invalid, such as hypoxic or ischemic conditions.
- Evident from the text: external blood glucose and lactate concentrations were kept fixed in all simulations, and gluconeogenic substrates other than lactate were neglected.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Glycogen metabolism and hormone perturbations. (A) Decrease in glycogen during short term fasting over 60 h. Experimental data from [22] (individual data) and [23] (mean data with STD) given in Dataset S1. Simulation time courses (dashed lines) start from filled glycogen stores (500 mM). Blood glucose is varied between 3.6 mM (red) and 5.0 mM (green) in steps of 0.2 mM (black). The blue curve corresponds to a situation where the plasma glucose concentration changes from initially 5 mM to 3.6 mM in 60 h. Higher blood glucose results in a slower decrease in glycogen. (B) Increase in glycogen after a glucose load. Experimental data from [8], [24], [25] given in Dataset S1. Simulation time courses (dashed lines) start from initial glycogen concentration of 200 mM. Blood glucose concentrations are varied between 5.5 mM (red) and 8.0 mM (green) in steps of 0.5 mM (black). The blue line corresponds to 7 mM. Higher blood glucose results in a faster increase in glycogen after a glucose load. (C) Change in HGP and plasma glucose in insulin deficiency. Insulin (blue) and glucagon (red) time courses for an idealized hormone perturbation (left), the experimental data from [27] (middle), and a simulation taking the experimental profile of hormones and glucose utilization into account are shown in the top row. Middle row depicts the time courses of HGP (red) and whole-body glucose utilization GU (black). Bottom row shows the resulting change in plasma glucose as a consequence of the changes in HGP. Insulin deficiency increases HGP relative to GU resulting in an increase in plasma glucose. After insulin normalization HGP decreases and falls below GU due to the increased blood glucose. (D) Changes in HGP during the infusion period (135–200 min) relative to the pre-infusion period (85–135 min) for the simulations and experiments and the various hormone perturbations. Saline infusion (Figure S1) and somatostatin infusion with insulin and glucagon restauration (Figure S5) have no effect on basal HGP. Insulin and glucagon deficiency (Figure S2) and glucagon deficiency alone (Figure S3) decrease HGP relative to basal values. Insulin deficiency increases basal HGP (Figure 4C, Figure S4).](https://figures.cochat.ai/paper-figures/87490a05018a4b85974b7ba672eac06d/quantifying-the-contribution-of-the-liver-to-glucose-homeostasis-a-detailed-figure-4.jpg)
![Figure 5 HGP/HGU and HGRC. Steady state solution of time course simulations under constant glycogen and blood glucose concentration (every data points correspond to a single simulation to steady state). Glycogen is varied between 0 and 500 mM in steps of 5 mM, blood glucose is varied between 2 and 14 mM in steps of 0.05 mM. (A) HGP (red)/HGU (green) ([]) corresponding to GLUT2 flux. The liver switches between HGP and HGU depending on the blood glucose and glycogen. The set point varies between 5.4 mM for empty and 7.5 mM for completely filled glycogen stores (6.6 mM at glycogen 250 mM). (B) HGRC ([]). Response of the liver to changes in the blood glucose. Two main regions of high response exist: A hypoglycemic region below 4 mM, and a hyperglycemic region above 8 mM glucose. (C) gluconeogenesis (red)/glycolysis (green) ([]) corresponding to glucose-6p isomerase (GPI) flux. The gluconeogenesis/glycolysis set point varies between 8.8 mM for empty and 7.0 mM for filled glycogen stores. (D) glycogenolysis (red)/glycogenesis (green) ([]) corresponding to flux through glucose-1p isomerase (G1PI).](https://figures.cochat.ai/paper-figures/4d457956c15a4280b6d22553178050f2/quantifying-the-contribution-of-the-liver-to-glucose-homeostasis-a-detailed-figure-5.jpg)
Verification
Claims the paper makes
10 Valid · 0 Not valid · 19 Not checked · 112 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The simulations for short term fasting under constant glucose concentrations between 5 mM (green) and 3 mM (red), the normal range of fasting glucose concentration [22], [23], are in agreement with the experimental data (Figure 3, Table 2).”
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Results > HGP, gluconeogenesis and glycogenolysis in short term fasting
What the sources say
- Not checked — no full text of the sourcecites [22] Rothman DL Magnusson I Katz LD Shulman RG Shulman GI 1991 Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR. Science 254 573 576 1948033 source
- Partly supportedcites [23] Magnusson I Rothman DL Katz LD Shulman RG Shulman GI 1992 Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. J Clin Invest 90 1323 1327 1401068 PMC443176 sourceExperimental — accuracy not yet measured
The citation is attached to the description of 3–5 mM as the normal fasting-glucose range, not to the citing authors’ conclusion about their simulations. Table I in the Results reports fasting plasma glucose of 5.4 ± 0.2 and 5.1 ± 0.2 mmol/L in healthy controls after 16 and 23 hours, respectively, but does not establish 3 mM as a normal lower bound. (LLM, conf=0.85)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“To further evaluate the predictive capacity of our model, we performed time-course simulations of experimentally determined glycogen levels in dogs monitored under conditions of hyperglycemic, hyperinsulinemic clamps and administration of a mixed meal diet [26], as can be seen from the respective figures in the supplement (Figure S1, S2, S3, S4, S5, S6), our model simulation were in good agreement”
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Results > Glycogen synthesis postprandial
What the sources say
- Partly supportedcites [26] Krssak M Brehm A Bernroider E Anderwald C Nowotny P 2004 Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes. Diabetes 53 3048 3056 15561933 sourceExperimental — accuracy not yet measured
The Research Design and Methods section describes human participants, not dogs, in both the mixed-meal and clamp protocols. Figure 3 reports measured hepatic glycogen time courses for those participants under both conditions. The cited paper therefore supports the use of experimental glycogen time courses, but not their attribution to dogs; the citing authors' model agreement is their own conclusion. (LLM, conf=0.90)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 6 assumptions not shown here.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“For all hormone perturbations the time courses of HGP as well as glucose are in good agreement with the experimentally observed changes.”
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Results > Role of insulin and glucagon for HGP
What the sources say
- Supportedcites [27] Cherrington AD Chiasson JL Liljenquist JE Jennings AS Keller U 1976 The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog. J Clin Invest 58 1407 1418 993351 PMC333312 source
The Methods describe the hormone perturbations, and the Figure 1–2 captions in the Regulation of Glucose Production by Insulin and Glucagon section identify measured time courses of glucose production and plasma glucose concentration in dogs. The cited paper supplies the experimental observations; the judgment that another set of time courses agrees with them is the citing authors’ own comparison. (LLM, conf=0.85)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 6 assumptions not shown here.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The simulations for glycogen depletion under hypoglycemia (Figure 4A) for glucose concentrations between 3.6 mM (red) and 5 mM (green) are in agreement with experimental data [22], [23].”
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Results > Glycogenolysis in short term fasting
What the sources say
- Not checked — no full text of the sourcecites [22] Rothman DL Magnusson I Katz LD Shulman RG Shulman GI 1991 Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR. Science 254 573 576 1948033 source
- Partly supportedcites [23] Magnusson I Rothman DL Katz LD Shulman RG Shulman GI 1992 Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. J Clin Invest 90 1323 1327 1401068 PMC443176 sourceExperimental — accuracy not yet measured
The Results (page not supplied) report a significant decline in liver glycogen during fasting in both diabetic and control subjects. They do not report hypoglycemia at 3.6–5 mM or compare those conditions with the citing paper’s simulations; the reported mean fasting glucose concentrations were 5.1–5.4 mM in controls and higher in diabetic subjects. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Changes in gene expression play a role in adapting hepatic metabolism on longer time scales to for example reduce futile cycles in counteracting pathways (like down-regulation of glucokinase and up-regulation of glucose-6 phosphatase under hypoglycemia) or match glucose metabolism to physiological requirements (up-regulating of glucose-6 phosphatase under hypoglycemic conditions to increase glucon”
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Discussion
What the sources say
- Supportedcites [31] Vollmers C Gill S DiTacchio L Pulivarthy SR Le HD 2009 Time of feeding and the intrinsic circadian clock drive rhythms in hepatic gene expression. Proc Natl Acad Sci U S A 106 21453 21458 19940241 PMC2795502 source
The Discussion (“Food Modulated Transcripts Constitute a Metabolic Sand Timer”; page unavailable) reports that hepatic transcripts change with feeding and fasting, with fasting-induced transcripts accumulating as fasting continues. The Results (“Daily Rhythms in Metabolic Regulators”; page unavailable) link these changes to regulators of cellular energy metabolism, supporting the broad claim about gene expression and longer-term metabolic adaptation. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
74 more claims · 3 with their cited sources checked
Create a free account to see all 141 claims and every source verdict.
- It may state two separate claims as one. 53
- Probably not a substantial claim. 14
- The quote only partly states this claim. 2
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| 2H2O | [56] | 10 | 12.2 | 7.4 | 3.8 | 60 |”
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Methods > Hepatic glucose production, gluconeogenesis and glycogenolysis
Reported 12.2 · recomputed 11.2
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| 2H2O | [67] | 16 | 17.5 | 8.9 | 8.2 | 51 |”
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Methods > Hepatic glucose production, gluconeogenesis and glycogenolysis
Reported 17.5 · recomputed 17.1
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| 13C-glucose (a) | [58] | 18 | 8.5 | 5.9 | 2.6 | 59 |”
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Methods > Hepatic glucose production, gluconeogenesis and glycogenolysis
Reported 59 · recomputed 69.411765
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| 13C-glycerol MIDA | [49] | 60 | 7.87 | 7.71 | 1.58 | 98 |”
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Methods > Hepatic glucose production, gluconeogenesis and glycogenolysis
Reported 7.87 · recomputed 9.29
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Results
“Blood glucose is varied between 3.6 mM (red) and 4.6 mM (green) in steps of 0.2 mM.”
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Results > HGP, gluconeogenesis and glycogenolysis in short term fasting
“The simulations for short term fasting under constant glucose concentrations between 5 mM (green) and 3 mM (red), the normal range of fasting glucose concentration [22], [23], are in agreement with the experimental data (Figure 3, Table 2).”
1 more finding
Create a free account to see every finding of this check.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441
Meal Simulation Model of the Glucose-Insulin System
Dalla Man, C., Rizza, R. A., & Cobelli, C. (2007) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2007.893506 · Cited by 955
Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis.
Pilkis, S. J., & Granner, D. K. (1992) · Annual Review of Physiology · doi:10.1146/annurev.ph.54.030192.004321 · Cited by 865
Time of feeding and the intrinsic circadian clock drive rhythms in hepatic gene expression.
Vollmers, C., Gill, S., DiTacchio, L., Pulivarthy, S. R., Le, H. D., & Panda, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909591106 · Cited by 765 · cited 1×
“is strongly dependent on the external concentration of glucose and to a much lesser extent on the glycogen level. (ii) Under hypoglycemic conditions main control of hepatic glucose metabolism is exerted by a completely different set of reactions than in hyperglycemia. (iii) The response of the opposing pathway couples…”
BackgroundMagnusson, I., Rothman, D. L., Katz, L. D., Shulman, R. G., & Shulman, G. I. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115997 · Cited by 757
Mitrakou, A., Kelley, D., Mokan, M., Veneman, T., Pangburn, T., Reilly, J., & Gerich, J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201023260104 · Cited by 595
Zonation of parenchymal and nonparenchymal metabolism in liver.
Jungermann, K., & Keitzmann, T. (1996) · Annual Review of Nutrition · doi:10.1146/annurev.nu.16.070196.001143 · Cited by 589 · cited 1×
“A model is always an abstraction of reality describing a certain subset of biological phenomena. The underlining assumptions are crucial for to understand the range of application of the model and the limitations. Main model assumptions and simplifications are (i) usage of phenomenological functions to incorporate hor…”
BackgroundMitrakou, A., Ryan, C., Veneman, T., Mokan, M., Jenssen, T., Kiss, I., Durrant, J., Cryer, P., & Gerich, J. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.260.1.e67 · Cited by 558
Cited by
Items 101–200 of 203
Bansode, T., Salalkar, B., Dighe, D. D., Nirmal, S., & Dighe, S. (2017) · Ayu · doi:10.4103/ayu.ayu_18_17 · Cited by 11
“In people with diabetes, liver looses its normal capacity to synthesize glycogen as glycogen synthase activation becomes defective.[32] Therefore, our result showed”
Modelling the effects of glucagon during glucose tolerance testing
Kelly, R. A., Fitches, M. J., Webb, S. D., Pop, S. R., & Chidlow, S. J. (2019) · Theoretical Biology and Medical Modelling · doi:10.1186/s12976-019-0115-3 · Cited by 11
Main glucose hepatic fluxes in healthy subjects predicted from a phenomenological-based model
Builes-Montaño, C. E., Lema-Pérez, L., Garcia‐Tirado, J., & Álvarez, H. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105232 · Cited by 10
Modeling of glycosaminoglycan biosynthesis in intervertebral disc cells
Huang, C.-Y. C., Loo, D. M., & Gu, W. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107039 · Cited by 10
Rezania, V., Coombe, D., & Tuszyński, J. A. (2020) · Journal of Functional Biomaterials · doi:10.3390/jfb11010013 · Cited by 11
Feng, F., Chen, L., Lian, C., Xia, H., Zhou, Y., Yao, Q., & Chen, K. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2014.05.015 · Cited by 10
Glycolysis Is Governed by Growth Regime and Simple Enzyme Regulation in Adherent MDCK Cells
Rehberg, M., Ritter, J. B., & Reichl, U. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003885 · Cited by 15
“Figure S2 Adjusting the segregated growth model established previously [14] to MDCK cell proliferation in 6-well plates using DMEM medium.”
BackgroundMethodBawden, S. J., Stephenson, M. C., Ciampi, E., Hunter, K., Marciani, L., Spiller, R. C., Aithal, G. P., Morris, P. G., Macdonald, I. A., & Gowland, P. A. (2014) · Food & Function · doi:10.1039/c4fo00050a · Cited by 10
Niklas, J., Ochoa, J. G. D., Bucher, J., & Mauch, K. (2012) · Molecular Informatics · doi:10.1002/minf.201200043 · Cited by 10
Xiao, X., Erukainure, O. L., & Islam, M. S. (2023) · Food Science and Human Wellness · doi:10.1016/j.fshw.2023.03.018 · Cited by 10
Kinetic modelling of the cellular metabolic responses underpinning in vitro glycolysis assays
Patil, N., Mirveis, Z., & Byrne, H. J. (2024) · FEBS Open Bio · doi:10.1002/2211-5463.13765 · Cited by 12
“Several models for glucose catabolism or glycolysis, using ODE’s similar to the model developed in this study, can be found, for example, in the BioModels repository, which vary in their complexities and sophistication [80 – 83].”
MethodWierling, C. (2014) · Hepatology · doi:10.1002/hep.27364 · Cited by 10
Liébana-García, R., Olivares, M., Rodríguez‐Ruano, S. M., Tolosa-Enguís, V., Chulia, I., Gil-Martínez, L., Guillamón, E., Baños, A., & Sanz, Y. (2022) · Nutrients · doi:10.3390/nu14030440 · Cited by 11
Timing of caffeine ingestion alters postprandial metabolism in rats
Jarrar, S. F., & Obeid, O. (2013) · Nutrition · doi:10.1016/j.nut.2013.07.015 · Cited by 11
Dietary Betaine Improves Glucose Metabolism in Obese Mice
Xu, G., Pan, H., Fan, L., Zhang, L., Li, J., Cheng, S., Meng, L., Shen, N., Liu, Y., Li, Y., et al. (2024) · Journal of Nutrition · doi:10.1016/j.tjnut.2024.02.025 · Cited by 10
Somvanshi, P. R., Patel, A. K., Bhartiya, S., & Venkatesh, K. V. (2016) · RSC Advances · doi:10.1039/c5ra18128c · Cited by 9
“The 134 parameters for hepatic metabolism were extracted from Konig et al. 2012 and Xu et al. 2011 (38, 135 42), for insulin signaling from Sedaghat et al 2002(43), for glucagon signaling from Xu et al. 136 2011 and Mutalik et al 2005(42, 44), for mTOR signaling from Vinod and Venkatesh 2009(45)…”
MethodInfluentialSchlicker, L., Zhao, G., Dudek, C.-A., Boers, H. M., Meyer‐Hermann, M., Jacobs, D. M., & Hiller, K. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.785999 · Cited by 14
“The fitting procedure was guided by minimizing the root mean square (RMS) difference between (scaled) model output (y) and the measured data point (ŷ) referred to as “cost” throughout the manuscript (Equation 5).”
BackgroundMethodInfluentialComputational Modelling of Liver Metabolism and its Applications in Research and the Clinics
Tomaš, T. C., Moškon, M., Mraz, M., & Rozman, D. (2018) · Acta chimica slovenica · doi:10.17344/acsi.2018.4461 · Cited by 10
O’Brien, C. M., Allman, A., Daoutidis, P., & Hu, W. (2019) · Metabolic Engineering · doi:10.1016/j.ymben.2019.08.005 · Cited by 9
Alterations of Central Liver Metabolism of Pediatric Patients with Non-Alcoholic Fatty Liver Disease
Berndt, N., Hudert, C. A., Eckstein, J., Loddenkemper, C., Henning, S., Bufler, P., Meierhofer, D., Sack, I., Wiegand, S., Wallach, I., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911072 · Cited by 10
“, impaired insulin secretion, the situation is entirely different: Deficiency of insulin and relative excess of glucagon increase the expression of key enzymes of gluconeogenesis and regulate interconvertible enzymes toward glucose production, thus converting the liver into a glucose producer similar to under conditio…”
BackgroundSelf-citationCold Exposure Improves the Anti-diabetic Effect of T0901317 in Streptozotocin-Induced Diabetic Mice
Gao, M., Zhang, C., Ma, Y., & Liu, D. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9746-4 · Cited by 9
5-azacytidine promotes terminal differentiation of hepatic progenitor cells
He, Y., Cui, J., He, T., et al. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3772 · Cited by 8
“Synthetic glycogen appears a purple-red color in the cytoplasm, upon PAS staining (22).”
Executable Simulation Model of the LiverPreprint
König, M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.04.894873 · Cited by 8
Self-citationA mechanobiological mathematical model of liver metabolism
Nikmaneshi, M. R., Firoozabadi, B., & Munn, L. L. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27451 · Cited by 8
“Liver glucose metabolism has been mathematically modeled in both intra ‐ hepatocellular microscale (Domach, Leung, Cahn, Cocks, & Shuler, 2000; König, Bulik, & Holzhütter, 2012; London, 1966) and multicellular macro-scale models (W. B. Ashworth, Davies, & Bogle, 2016; Hsu, Tan, Tania, Birgersson, &…”
Intrapatient repeatability of background 18F-FDG uptake on PET/CT
Wang, R., Fan, Q., Tian, R., & Su, M. (2021) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-20-769 · Cited by 7
“This may be attributed to the liver’s crucial role in maintaining the homeostasis of the BGL under various physiological states (29,30).”
BackgroundRazliqi, R. N., Harooni, E., Neisi, N., Sameri, M. J., & Ahangarpour, A. (2023) · PubMed Central · doi:10.22038/ijbms.2023.70659.15359 · Cited by 6
“One of these complications is liver injury, which is very important due to the organ’s crucial role in lipid and carbohydrate homeostasis (22).”
BackgroundThe Yin Yang of Hormones that Control Glucose Homeostasis in Asthma
Insuela, D. B. R. (2013) · Journal of Allergy & Therapy · doi:10.4172/2155-6121.s11-001 · Cited by 6
“Although, epinephrine is less potent in inducing hyperglycemia than glucagon, epinephrine becomes essential in the control of glucose homeostasis when glucagon actions are impaired, [72].”
BackgroundChalhoub, E. R., & Belovich, J. (2022) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2022.109148 · Cited by 6
Ramos, J. R. C., Bissinger, T., Genzel, Y., & Reichl, U. (2022) · Metabolites · doi:10.3390/metabo12030239 · Cited by 7
Brunasso, A., Man, C. D., Poli, S., Prompers, J. J., Herzig, D., Kreis, R., Bally, L., & Schiavon, M. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00511.2024 · Cited by 5
CKD subpopulations defined by risk‐factors: A longitudinal analysis of electronic health records
Ramaswamy, R., Wee, S. N., George, K., Ghosh, A., Sarkar, J., Burghaus, R., & Lippert, J. (2021) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12695 · Cited by 7
A Graph-Based Framework for Multiscale Modeling of Physiological Transport
Maheshvare, M. D., Raha, S., & Pal, D. (2022) · Frontiers in Network Physiology · doi:10.3389/fnetp.2021.802881 · Cited by 4
Fousteri, G., Jones, M., Novelli, R., Boccella, S., Brandolini, L., Aramini, A., Pozzilli, P., & Allegretti, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1576371 · Cited by 8
“In soleus muscle tissue from obese db/db Frontiers in Immunology 05 frontiersin.org Finally, the liver is a key insulin-sensitive organ which in fl uences glucose homeostasis (111).”
Modeling sex-specific whole-body metabolic responses to feeding and fasting
Abo, S. M. C., & Layton, A. T. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.109024 · Cited by 7
Pan, Y., Hatano, A., Ohno, S., Morita, K., Kokaji, T., Bai, Y., Sugimoto, H., Egami, R., Terakawa, A., Li, D., et al. (2024) · npj Systems Biology and Applications · doi:10.1038/s41540-024-00437-2 · Cited by 10
A multiscale-multiphysics framework for modeling organ-scale liver regrowth
Ebrahem, A., Hohl, J., Jessen, E., ten Eikelder, M. F. P., & Schillinger, D. (2025) · Journal of the Mechanics and Physics of Solids · doi:10.1016/j.jmps.2025.106113 · Cited by 5
Antidiabetic Medicinal Plants and Their Mechanisms of Action
Saad, B., Zaid, H., Shanak, S., & Kadan, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-54102-0_7 · Cited by 6
Inhibition of metabolic disorders in vivo and in vitro by main constituent of Coreopsis tinctoria
Jiang, B., Lv, Q., Xiang, J., Le, L., Hu, K., Xu, L., & Xiao, P. (2018) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2018.03.004 · Cited by 4
Selvam, R., Koothappan, M., & Subramanian, S. P. (2018) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2018.v11i10.28152 · Cited by 7
Multiomic Data Integration and Analysis via Model-Driven Approaches
de Mas, I. M. (2018) · Comprehensive analytical chemistry · doi:10.1016/bs.coac.2018.07.005 · Cited by 5
Executable Simulation Model of the Liver
König, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11682-4 · Cited by 9
Self-citationSathyanarayan, S., & Pillai, K. S. (2019) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v9i4-a.3394 · Cited by 5
A Consensus Model of Glucose-Stimulated Insulin Secretion in the Pancreatic β -CellPreprint
Maheshvare, M. D., Raha, S., König, M., & Pal, D. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.10.532028 · Cited by 3
Self-citationHelleputte, S., Podlogar, T., & Gonzalez, J. T. (2025) · Performance Nutrition · doi:10.1186/s44410-025-00013-7 · Cited by 11
“There is a harmonious interplay between insulin and counterregulatory hormones (glucagon, cate-cholamines, cortisol and growth hormone) in response to varying serum glucose concentrations [45], with a pivotal role for the liver [43].”
InfluentialLiao, Y., Davies, N. A., & Bogle, I. D. L. (2022) · Chemical Engineering Science · doi:10.1016/j.ces.2022.118131 · Cited by 3
Genetically encoded bioluminescent glucose indicator for biological research
Tanaka, R., Sugiura, K., Osabe, K., Hattori, M., & Nagai, T. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.151092 · Cited by 4
Nutrients and Liver Metabolism
Gyamfi, D., & Danquah, K. O. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800773-0.00001-x · Cited by 5
Komori, K., Usui, M., Hatano, K., Hori, Y., Hirono, K., Zhu, D., Tokito, F., Nishikawa, M., Sakai, Y., & Kimura, H. (2021) · Bioelectrochemistry · doi:10.1016/j.bioelechem.2021.107972 · Cited by 5
Tautenhahn, H., Ricken, T., Dahmen, U., Mandl, L., Bütow, L., Gerhäusser, S., Lambers, L., Chen, X., Lehmann, E., Dirsch, O., et al. (2024) · GAMM-Mitteilungen · doi:10.1002/gamm.202370003 · Cited by 5
“To incorporate the metabolic processes at the cellular scale, this model was integrated with the ODE-metabolism models developed by König [17] and Schleicher [33].”
MethodSelf-citationMartyshina, A. V., Sirotkina, A. G., & Gosteva, I. V. (2024) · Biosystems · doi:10.1016/j.biosystems.2024.105227 · Cited by 3
Succinate aggravates NAFLD progression to liver cancer on the onset of obesity: Anin silicomodel
Ray, I., Dasgupta, A., & De, R. K. (2018) · Journal of Bioinformatics and Computational Biology · doi:10.1142/s0219720018500087 · Cited by 3
A graph-based framework for multi-scale modeling of physiological transportPreprint
Maheshvare, M. D., Raha, S., & Pal, D. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.14.460337 · Cited by 3
“These models capture the dependency of intracellular dynamics onmetabolic steady states and flux distributions (König et al., 2012; Berndt et al., 2018a; Masid et al., 2020).”
BackgroundGerhäusser, S., Lambers, L., Mandl, L., Franquinet, J., Ricken, T., & König, M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.26.586870 · Cited by 4
“Metabolic models allow to describe the metabolic processes that take place within the liver cells, such as glucose metabolism [6, 7], lipid metabolism [8], central metabolism [9], or drug detoxification [10, 11].”
BackgroundSelf-citationA Computational Glucoregulatory Model of Liver and Glucagon for the Evaluation of Therapeutics
Gong, X., Alizadehmojarad, A. A., Machado, M., Yang, S., & Strano, M. S. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00177 · Cited by 2
Kinetic‐model‐based pathway optimization with application to reverse glycolysis in mammalian cells
Lu, Y., Brien, C. M. O., Mashek, D. G., Hu, W., & Zhang, Q. (2022) · Biotechnology and Bioengineering · doi:10.1002/bit.28249 · Cited by 2
“Reaction equations and parameters of ℛ are collected from liver models [39,40].”
Martyshina, A. V., & Dokukina, I. V. (2022) · Communications in computer and information science · doi:10.1007/978-3-031-24145-1_10 · Cited by 4
Control óptimo de la glucosa en la sangre mediante infusión continua de insulina
Panqueba, E. F., & Vera, J. M. R. (2022) · CIENCIA EN DESARROLLO · doi:10.19053/01217488.v13.n2.2022.14173 · Cited by 2
Suriyah, W. H., Ichwan, S., Kasmuri, A., & Taher, M. (2019) · Makara Journal of Health Research · doi:10.7454/msk.v23i1.10153 · Cited by 5
“Investigating the effect of new drug candidates on hepatic glucose metabolism is essential because the liver is the main organ for controlling blood glucose.(14) This in vitro research was”
BackgroundControl Methods in Automated Glycemia Maintaining System
Витольдович, П. К., Bazaev, N. A., & Litinskaia, E. L. (2020) · IEEE Conference of Russian Young Researchers in Electrical and Electronic Engineering · doi:10.1109/eiconrus49466.2020.9039391 · Cited by 2
Dynamic Modeling and Stochastic Simulation of Metabolic NetworksPreprint
Clement, E. J., Soliman, G. A., Wysocki, B. J., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/336677 · Cited by 2
Gut Microbes and the Liver Circadian Clock Partition Glucose and Lipid MetabolismPreprint
Frazier, K., Manzoor, S. S., Carroll, K., DeLeon, O., Miyoshi, S., Miyoshi, J., George, M. S., Tan, A., Izumo, M., Takahashi, J. S., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.24.491361 · Cited by 2
Cuadros, A. M., Fernández-García, J., Planque, M., Altea‐Manzano, P., Schalley, T., Vermeire, I., Broekaert, D., Wu, Q., Brussel, T. V., Leduc, S., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.03.506468 · Cited by 3
“We then adjusted the concentrations of glucose and alanine in culture medium within physiologic ranges (520mM glucose, 250-450uM alanine) (Johnson et al., 1990; König et al., 2012; Petersen et al., 2019; Rossiter et al., 2021).”
BackgroundMethodRashwan, A. G., Assar, D. H., Salah, A. S., Abualreesh, M. H., Salem, S. M. R., Althobaiti, N. A., & Elbialy, Z. I. (2025) · Scientific Reports · doi:10.1038/s41598-024-84814-1 · Cited by 1
“Furthermore, decreasing hepatic glycogen levels may also reduce glucose yield from the liver, as the rate of glycogenolysis is known to be proportional to the amount of glycogen 85 .”
Miura, Y., Sakai, Y., Nishikawa, M., & Leclerc, É. (2025) · Toxicological Sciences · doi:10.1093/toxsci/kfaf176 · Cited by 2
Modeling of the Human Pancreas Function in Glucose Homeostasis
E, Y. C. V., & Julián Martínez, G. (2018) · doi:10.23919/aadeca.2018.8577449 · Cited by 1
“[9] König, Matthias and Bulik, Sascha and Holzhütter, Hermann-Georg, “Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism,” PLoS Computational Biology, vol.”
BackgroundExploring the nutritional factors and health benefits of artisanal alcoholic rice beverages
Das, S., & Khan, M. R. (2023) · International Journal of Science and Research Archive · doi:10.30574/ijsra.2023.8.2.0236 · Cited by 1
The Effect of Sacha Inchi Tempe on Blood Glucose, HOMA-IR, and TNF-ɑ in Rats with Metabolic Syndrome
Setyawati, A. R., Anjani, G., Mahati, E., Afifah, D. N., Syauqy, A., Astawan, M., & Rahmawati, I. S. (2024) · Jurnal Gizi dan Pangan · doi:10.25182/jgp.2024.19.2.97-106 · Cited by 2
“This is because the liver is the primary organ responsible for controlling blood glucose, insulin, glucagon, and epinephrine (König et al. 2012).”
BackgroundGhosh, S., Sengupta, A., Sharma, S., & Sonawat, H. M. (2019) · Concepts in Magnetic Resonance Part A · doi:10.1155/2019/3542393 · Cited by 1
“Liver, on the other hand is one of the major sites of metabolic processes and is the primary regulatory site for blood glucose homeostasis [21].”
BackgroundThe effect of two diets with different carbohydrate content on glucose markers in dogs
Brännback, E. (2020) · Helda - University of Helsinki Institutional Repository · Cited by 1
Metabolomic profiling reveals effects of marein on energy metabolism in HepG2 cellsPreprint
Jiang, B., Le, L., Hu, K., Xu, L., & Xiao, P. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/176495 · Cited by 1
“The liver 61 is the primary organ responsible for regulating glucose homeostasis ([6]).”
BackgroundHoehme, S., Gebhardt, R., Hengstler, J. G., & Drasdo, D. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2005.09151 · Cited by 1
“Recently, significant effort has been made towards mathematical models on blood or lymph flow, molecular transport, or metabolism in liver [4, 5, 7, 8, 15–17, 28, 37, 38, 45, 47–49].”
BackgroundA Theoretical Model of Mitochondrial ATP Synthase Deficiencies. The Role of Mitochondrial Carriers
Mazat, J., Devin, A., Yoboue, E. D., & Ransac, S. (2021) · Processes · doi:10.1101/2021.07.13.452228 · Cited by 1
“The Odc1p overexpression presumably increases AKG uptake in mitochondria with succinate or malate exchange promoting the subsequent increase in ATP synthesis by SLP (SLP‐ATP) [7].”
BackgroundInfluentialCasas, B., Vilén, L. K., Bauer, S., Kanebratt, K. P., Huldt, C. W., Magnusson, L. U., Marx, U., Andersson, T. B., Gennemark, P., & Cedersund, G. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.18.456693 · Cited by 1
“We may then expand our current computational framework by incorporating more detailed models of hepatic glucose metabolism (König et al., 2012; Ashworth et al., 2016) for further elucidation of mechanisms behind T2DM and refined in silico predictions.”
Nyman, E. (2014) · Linköping University Electronic Press eBooks · doi:10.3384/diss.diva-104725
Insulin signaling dynamics in human adipocytes
Nyman, E. (2014)
An in Silico Liver: Model of Gluconeogenesis
Chalhoub, E. R. (2013) · EngagedScholarship @ Cleveland State University (Cleveland State University) · Cited by 1
IL-6 and GLP-1 in body fat regulating parts of the CNS in healthy mice
Anesten, F. (2016) · Gothenburg University Publications Electronic Archive (Gothenburg University)
FACULTE DES SCIENCES BIOLOGIQUES ET PHARMACEUTIQUES
Oualha, M. (2013)
The Hormones of Glucose Metabolism
Shaw, T., Handley, C., & Hall, M. S. (2014) · Aquila Digital Community (University of Southern Mississippi)
Simulation of central glucose metabolism using queueing network
Wysocki, B. J., Clement, E. J., Davis, P. H., & Wysocki, T. A. (2017) · IEEE International Conference on Electro Information Technology · doi:10.1109/eit.2017.8053358
“Values that were not provided or were substantially different from other sources were obtained through additional literature searches [9], [10], [13], [15], [16].”
BackgroundNkemzi, A. Q. (2017) · ResearchSpace (University of KwaZulu-Natal)
Application of CellDesigner program for nutrition planning and food safety control
Marić, L., Malešić, E., Šanko, K., et al. (2019) · Journal on Processing and Energy in Agriculture · doi:10.5937/jpea1901032m
“Model of the glycolysis metabolism Mathematical model of glucose metabolism in liver cells developed by König et al., 2012 was analysed.”
MethodAutomated Blood Glucose Control System
Litinskaia, E. L., & Витольдович, П. К. (2019) · doi:10.1109/cts48763.2019.8973284
“There is a complex system of hormonal regulation of carbohydrate metabolism [3, 4] to maintain a stable BG level.”
BackgroundMetabolic Modeling and Omics Data Integration: A Systems Biology Approach to Food Science
de Mas, I. M., de Leeuw, M., Ghaffari, P., & Nielsen, L. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-100596-5.22914-4
Nutritional Supplementation for Patients with Decompensated Cirrhosis
Vidot, H., & Shackel, N. A. (2021) · Current Hepatology Reports · doi:10.1007/s11901-021-00561-1
Johnson, O. R., Paul, G. M., Magellan, D. D., Dangara, D. N., & Gyebi, G. A. (2022) · Acta Parasitologica · doi:10.1007/s11686-022-00550-4 · Cited by 1
Fares, E.-J. (2022) · American Journal of Biomedical Science & Research · doi:10.34297/ajbsr.2022.15.002112
The M2 Pipeline: A Novel Tool for Rapidly Analyzing Host Metabolic Profiles from RNA-seq Data
Baker, R., Bassaganya-Riera, J., Tubau‐Juni, N., Leber, A. J., & Hontecillas, R. (2023) · International Conference on Bioinformatics and Computational Biology (ICBCB) · doi:10.1109/icbcb57893.2023.10246649
Computational modeling and autonomic control
Suksasilp, C., Friston, K. J., & Garfinkel, S. N. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-820480-1.00076-0
Mathematical Modelling of MASLD ‐ Towards Digital Twins in Liver Disease
Simonsson, C. (2024) · Linköping studies in science and technology. Dissertations · doi:10.3384/9789180757348
Advances in the Clinical Study of Nuclear Overhauser Enhancement
Zhao, N., Shen, Y., Shi, D., Mao, Y., Wang, G., Xiao, G., Xu, D., & Yan, G. (2024) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.29623
“54 Hepatic glycogen maintains appropriate blood glucose levels, 55 whereas myocardial glycogen is essential for myocardial energy production.”
Modeling metabolic disease susceptibility and resilience in genetically diverse micePreprint
Baker, C. N., Harder, J. M., Skelly, D. A., Gyuricza, I. G., Gaca, M., Vincent, M. J., Ingalls, A., Keller, M. P., Attie, A., Braun, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.12.637923
Modeling metabolic disease susceptibility and resilience in genetically diverse micePreprint
Baker, C. N., Harder, J. M., Skelly, D. A., Gyuricza, I. G., Gaca, M., Vincent, M. J., Ingalls, A., Keller, M. P., Attie, A., Braun, M., et al. (2025) · eLife · doi:10.7554/elife.108435
Modeling metabolic disease susceptibility and resilience in genetically diverse micePreprint
Baker, C. N., Harder, J. M., Skelly, D. A., Gyuricza, I. G., Gaca, M., Vincent, M. J., Ingalls, A., Keller, M. P., Attie, A., Braun, M., et al. (2025) · eLife · doi:10.7554/elife.108435.1
A proteomic approach for understanding the metabolic adaptations in non-small cell lung cancer
Martín-Bernabé, A. (2018) · theses.fr (ABES) · doi:10.70675/426e7b40z057az4326z8cfez7da3a5c12c7e
Han, X., Liu, T., Zeng, H., Liu, J., Lu, Z., Xu, J., Wang, J., Yang, X., Zhu, S., Ran, H., et al. (2026) · BMC Microbiology · doi:10.1186/s12866-026-05034-3 · Cited by 2
“The liver is crucial for energy metabolism and helps in maintaining blood glucose balance because of its role in regulating gluconeogenic processes [64].”
Kumutima, J., Yao, X., & Hamelberg, D. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6c00643
Joshi, D. M. (2026) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2026.110730
Metadata
- Authors
- König, M., Bulik, S., & Holzhütter, H.-G.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- Corresponding author
- König, Matthias
- Venue
- PLoS Computational Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-06-21
- Volume
- 8
- Issue
- 6
- Pages
- e1002577
- ISSN
- 1553-734X (ISSN-L)
- 1553-7358
- PMC
- PMC3383054
- OpenAlex
- W2019692827
- Semantic Scholar
- e736ceaff2e762e4127c5127aec4d667b24b6ace
- Cited by
- 202
- References
- 73
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 14 · 2023: 8 · 2022: 18 · 2021: 14 · 2020: 20 · 2019: 24 · 2018: 22 · 2017: 14 · 2016: 10 · 2015: 10 · 2014: 16 · 2013: 13 · 2012: 4
- FWCI
- 5.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Computational Biology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Keywords
- hepatic glucose metabolism, glucose homeostasis, kinetic model, hepatocytes, glycolysis, gluconeogenesis, glycogen metabolism, insulin, glucagon, epinephrine, hepatic glucose production, hepatic glucose utilization, glycogen storage, hypoglycemia, hyperglycemia, diabetes mellitus, glycogen storage disease
- MeSH terms
- Computer Simulation, Fasting, Glucagon, Gluconeogenesis, Glucose, Homeostasis, Humans, Hyperglycemia, Hypoglycemia, Insulin, Kinetics, Liver, Liver Glycogen, Models, Biological, Computational Biology, Postprandial Period, Glycogenolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.